Mercury accumulates in kidneys and produces acute kidney injury. Semen cassiae (SC), a widely consumed tea and herbal medicine in Eastern Asia, has been reported to have protective effects on kidneys. In this study, SC extract was shown to almost abolish the histological alterations induced by mercuric chloride in rat kidneys. A total of 22 compounds were isolated from SC, and 1,7,8-methoxyl-2-hydroxyl-3-methyl-anthraquinone was detected in SC for the first time. Among the eight compounds identified in the blood of rats after SC treatment, six were strong inhibitors of human organic anion transporter 1 and 3 (OAT1 and OAT3). Inhibitory studies revealed that OAT1 and OAT3 were inhibited by SC constituents, in both a competitive and noncompetitive manner. Both OAT1-and OAT3-overexpressing cells were susceptible to the cytotoxicity of the cysteine-mercury conjugate, but only OAT1-overexpressing cells could be protected by 200 lM probenecid or 10 lM of the eight inhibitors in SC, suggesting that OAT1 is the major determinant in the cellular uptake of mercury. To facilitate the identification of inhibitors of OAT1 and OAT3, models of OAT1 and OAT3 were constructed using recently determined protein templates. By combining in silico and in vitro methods, inhibitors of OAT1 and OAT3 were predicted and validated from SC constituents. Collectively, the present study suggests that additional inhibitors of OAT1 and OAT3 can be predicted and validated from natural products by combining docking and in vitro screening, and could be a source of pharmaceutical compounds for developing treatments for mercury-induced kidney injury.
Semen cassiae (SC) is commonly drunk as a roasted tea in Korea and China, and has been widely used in Eastern Asia as herbal medicines to relax the bowels, reduce inflammation, and improve eyesight (Zhang et al., 2012) . Semen cassiae has been used in the clinic to lower serum levels of triglycerides and lowdensity lipoprotein cholesterol in diabetes patients (Cho et al., 2005) . A recent study demonstrated that SC attenuates diabetic nephropathy, suggesting a protective role of SC in renal injuries (Kim et al., 2014) . However, it is not known whether SC could protect against mercury-induced renal toxicity.
Organic anion transporters (human: OATs; rodents: Oats) belong to the solute carrier (SLC) 22A transporter superfamily, which transports a variety of low molecular weight substrates (Takeda et al., 2002) . Among the OATs, OAT1 (SLC22A6) and OAT3 (SLC22A8) are almost exclusively expressed at the basolateral membrane of kidney proximal tubules and mediate the uptake of anionic substrates from blood into the proximal tubules, the first step of active renal tubular secretion. Numerous drugs have been identified as substrates or inhibitors of OAT1 and OAT3, including antibiotics, angiotensin-converting enzyme inhibitors, and nonsteroidal anti-inflammatory drugs (Nigam et al., 2015) . For this reason, both the food and drug administration and european medicine agency recommend that all new drugs undergo testing for their liability to interact with OAT1 and OAT3 (Tweedie et al., 2013) . Studies using cells expressing human OAT1 and rat Oat3 demonstrated that OATs mediate the cellular uptake of mercury-thiol conjugates (Aslamkhan et al., 2003; Zalups and Ahmad, 2005) . Oat1-null mice are resistant to HgCl 2 -induced renal injury (Torres et al., 2011) . Furthermore, HgCl 2 showed a lower renal impairment in female rats than males, largely because of the lower expression of Oat1 and Oat3 in female kidneys (Hazelhoff et al., 2012) . Therefore, inhibition of OAT1 and OAT3 might be an effective strategy to reduce mercury-induced renal injury.
Identification and characterization of OAT ligands could be facilitated by computational chemistry approaches based on atomic structures. However, so far there is no crystal structure available for any of the OATs. Homology-based modeling has been used to construct a human OAT1 structure model on the basis of the crystal structure of the bacterial glycerol-3-phosphate transporter (GlpT) (Perry et al., 2006; Tsigelny et al., 2008) . In contrast, no homology-based modeling studies have been reported for OAT3. Homology-based modeling could be improved once a crystal structure of protein with high sequence identity is available.
The present study demonstrated a protective role of SC on mercury-induced AKI in rats. The major constituents of SC were separated and identified in the blood of rats after SC treatment. To determine whether OAT1 and OAT3 were involved in the SCmediated protection on mercury toxicity, comparative models of OAT1 and OAT3 were constructed based on newly determined protein templates, and the interactions of SC constituents with OAT1 and OAT3 were evaluated by combining in silico and in vitro methods. Finally, the protective effect of SC constituents on mercury-induced renal toxicity was validated in kidney cells overexpressing OAT1 and OAT3.
MATERIALS AND METHODS
Chemicals. Probenecid (Prob; benzoic acid) (98%) and poly-D-lysine were purchased from Sigma-Aldrich Chem Co. (St. Louis, MO). Mercuric chloride was obtained from Beijing Chemistry Company (Beijing, China). 6-Carboxyfluorescein (6-CF) was obtained from Aladdin (Shanghai, China). Dulbecco's modified Eagle's medium (DMEM H-21), fetal bovine serum (FBS), and trypsin were bought from Gibco (Gaithersburg, MD). Hygromycin B was purchased from Solarbio (Beijing, China). Bicinchoninic acid (BCA) protein assay kit was bought from Cwbio (Beijing, China). All other reagents were purchased from commercial vendors and were of the highest purity grade available.
Extraction and isolation of major SC constituents. Dry SC was obtained from Hebei Meiwei TCM Material Company (Anguo City, Hebei province, China) and identified by Prof. Lijuan Zhang in Tianjin University of Traditional Chinese Medicine (TUTCM). A voucher specimen (No. 20140601) was deposited in the laboratory of Prof. Guanwei Fan (TUTCM, Tianjin, China). Semen cassiae (20 kg) was crushed and refluxed in 95% ethanol (3 Â 40 l) for a total of 6 h. The extract was concentrated to dryness under reduced pressure at 50 C. The residue was suspended in water (5 l) and partitioned with acetoacetate (EtOAc) (3 Â 5 l). The EtOAc fraction (550 g) was subjected to a silica gel chromatography column (CC) (CH 2 Cl 2 -MeOH, 20:1!10:1!5:1!2:1!1:1) to obtain five fractions (Fr. E1-5). Fr. E1 (100 g) was subjected to flash octadecylsilyl (ODS) CC (MeOH-H 2 O, 10:90!100:0) to yield 10 fractions (Fr. E1-1-10 Animal treatment. Gao et al. reported that 200 mg/kg of the total anthraquinones from Rhubarb could protect against HgCl 2 -induced kidney injury in rats without unknown mechanisms (Gao et al., 2016) . Semen cassiae contains about 0.85% anthraquinones, which are also major active components of SC (Zhang et al., 2012) . This prompted us to investigate the protective effect of SC on mercury toxicity. According to the literature, subcutaneous injection of a single dose (2-10 mg/kg) of HgCl 2 has been widely used to induce AKI in rats (Augusti et al., 2007; Bailey et al., 1973; Brunner et al., 1985) . In our preliminary study, rats were given 0, 2, 4, or 6 mg/kg HgCl 2 and kidneys were harvested after 72 h. The data suggested that only one-third of rats showed kidney injury when given 2 mg/kg HgCl 2 . Therefore, in the present study, 6 mg/kg HgCl 2 was chosen to ensure the kidney injury in all rats. In the preliminary study, 23 g/kg SC was chosen to achieve a similar dose (200 mg/kg) of anthraquinones as used in the previous study (Gao et al., 2016) . This dosage was found to be safe, and did not produce any sign of overt toxicity. Dry SC (4 kg) was crushed and extracted with 70% ethanol (40 l) under reflux (two times, each 2 h). The extract was concentrated under reduced pressure at 50
C to obtain 70% ethanol Blood biochemistry and histopathology. Serum samples were analyzed by standard enzymatic colorimetric assays using kits for blood urea nitrogen and creatinine (CREA) in accordance with the manufacturer's protocols (Jiancheng Bioengineering Institute, Nanjing, China). The major components of SC in blood of rats were separated by HPLC-mass spectrometry, and the peaks were identified by comparing to standards. Kidney tissues were homogenized in distilled water, centrifuged at 3500 Â g for 15 min at 4 C, and the supernatant was used for quantifying renal glutathione (GSH) concentration and glutathione peroxidase (GSH-PX) activity according to the manufacturer's instructions (Jiancheng Bioengineering Institute, Nanjing, China). The protein content was determined using a BCA Protein Assay Kit. For histopathology analysis, kidney samples were fixed in 10% neural buffered formalin and embedded in paraffin. Kidney sections (5 lm in thickness) were stained with hematoxylin and eosin for the evaluation of renal injuries.
Homology structure modeling of OAT1 and OAT3. The amino acid sequences of human OAT1 (Gene: SLC22A6; UniProt ID: Q4U2R8) and OAT3 (Gene: SLC22A8; UniProt ID: Q8TCC7) were submitted to the Molecular Operating Environment (MOE) (Chemical Computing Group, Montreal, Canada) in FASTA format for protein template search. The templates corresponding to the 2.9 Å structure of an eukaryotic phosphate transporter from Piriformospora indica (PiPT) (Protein Data Bank ID: 4J05) (Pedersen et al., 2013) and the 2.2 Å structure of Escherichia coli multidrug resistance transporter MdfA (Protein Data Bank ID: 4ZP2) (Heng et al., 2015) were identified and aligned with OAT1 and OAT3, respectively. Two series of OAT1 and OAT3 models were independently constructed by the MOE using a Boltzmann-weighted randomized modeling procedure to handle sequence deletions and insertions. Amber 10 was used as a force field. Afterward, the models with the best packing quality function were selected for full energy minimization, inspection and further modeling studies. Finally, the energy minimized OAT1 and OAT3 models were evaluated by the PROCHECK and ERRAT programs available from the UCLA Structure Analysis and Verification Server (Colovos and Yeates, 1993; Lovell et al., 2003) .
Molecular docking simulation. The protein models of OAT1 and OAT3 were 3D protonated and energy minimized by the MOE software with default parameters. The compounds were generated by Builder in MOE and were further energy minimized via MOE using the default parameters. Each compound was docked against predicted binding sites of OAT1 and OAT3 using MOEdock with most of the default tools to find the binding interaction of the ligand with the protein. The docking area was chosen based on the result of "SiteFinder," with the "Triangle Matcher" placement method and London dG scoring function selected for the docking process. The docking results were further validated with postplacement refinement, using the GBVI/WSA dG method. The docking results were stored in .mdb format. The best protein-ligand complex was selected based on binding free energy value, inhibition constants, and molecular interactions.
Cell culture. Human embryonic kidney (HEK) cell lines stably overexpressing human OAT1 and OAT3 were established and characterized previously in our laboratory (Lu et al., 2017) . Cell lines stably expressing empty vector (HEK-EV) and transporters (HEK-OAT1 and HEK-OAT3) were obtained by hygromycin B selection, and validated by both mRNA expression of transporters and their uptake of 6-CF, which is used as the fluorescent substrate for both OAT1 and OAT3 (Duan et al., 2012; Hsueh et al., 2016) . The cells were maintained in DMEM H-21 supplemented with 10% FBS, 1% penicillin/streptomycin, and 75 lg/ml hygromycin B at 37 C with 5% CO 2 .
In vitro uptake studies. A total of 5 Â 10 4 cells were seeded per well of 96-well culture plates precoated with poly-D-lysine. The cells were allowed to grow for 24 h until approximately 85% confluency. Prior to the uptake experiments, the cells were washed twice and preincubated with warm (37 C) uptake buffer (135 mM NaCl, 5 mM KCl, 2.5 mM CaCl 2 , 1.2 mM MgCl 2 , 0.8 mM MgSO 4 , 28 mM glucose, and 13 mM Hepes, pH 7.2) for 5 min. Uptake was conducted by incubating cells in the uptake buffer containing 5 lM 6-CF in the presence or absence of compounds for 5 min. Uptake was terminated by adding 100 ll ice-cold uptake buffer, and quickly washed three times with ice-cold phosphate-buffered saline buffer. The cells were lysed with 100 ll of 20 mM Tris-HCl containing 0.2% TritonX-100. An aliquot of 50 ll lysate was used to quantify fluorescence by using a Tecan Infinite M200 Microplate Reader (Tecan Austria GmbH A-5082 Grö dig, Austria) with excitation and emission wavelengths at 485 and 528 nm, respectively. The protein content of the solubilized cells was determined using a BCA Protein Assay Kit. The intensity of fluorescence was normalized to total protein. For IC 50 determination, the cells were incubated with uptake buffer containing 6-CF and serial dilution of inhibitors. IC 50 was determined using appropriate curve fitting. For Lineweaver-Burk plots, the cells were incubated with uptake buffer containing serial dilution of 6-CF and the inhibitor of interest at four different concentrations. The reciprocal value of 6-CF uptake at each inhibitor concentration was fitted by linear regression.
Cell viability testing. Cell viability was determined with an 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide based in vitro toxicology assay. Cells were seeded on a 96-well culture plates at a density of 1.2 Â 10 4 cells/well, and allowed to grow for 48 h until confluence. Cysteine-mercury conjugate (Cys-Hg) was prepared according to a previous method (Aslamkhan et al., 2003) . Cells were then incubated in DMEM containing test compounds with or without Cys-Hg (400 lM cysteine:100 lM Hg 2þ ), and were allowed to grow for 18 h. Media was discarded and cells were incubated with 0.5 mg/ml 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide in DMEM at 37 C for 4 h.
The medium was then replaced with 150 ll of DMSO, and the absorbance was quantified at 490 nm using a Tecan Infinite M200 Microplate Reader. Data were calculated as percent viability compared to controls.
Statistical analysis. Data are expressed as means 6 standard error of mean. Statistical analysis was performed using GraphPad Prism software, version 7.0. For the uptake experiments, data were analyzed with a two-tailed unpaired Student's t-test. For the animal studies, the differences between groups were analyzed using a one-way analysis of variance followed by a twoby-two comparisons using Tukey's test. The differences were considered significant at p < .05.
RESULTS

Protective Effect of SC Extract on Mercury-Induced Kidney Injury in Rats
To evaluate whether SC could protect against mercury-induced kidney injury, rats were intragastrically administered the SC extract for 6 days, followed by a single subcutenous injection of HgCl 2 on the fourth day. As expected, after three days of exposure, the survival rate was lower than 60% in the HgCl 2 -treated group ( Figure 1A ). In contrast, there were no deaths in the other three groups. Kidneys of the HgCl 2 -exposed rats had a white appearance with jellied enterocoelia exudates, whereas kidneys in the SC þ Hg had a color similar to the Cont group ( Figure 1B ). Histophathological analysis revealed marked necrosis in tubule epithelia cells in the HgCl 2 -treated rats, which were markedly decreased in the SC þ Hg-treated rats ( Figure  1B ). Blood urea nitrogen and CREA values were markedly increased in the blood of HgCl 2 -exposed rats, whereas both were decreased about 30% by cotreatment of SC ( Figure 1C ). Additionally, renal GSH was significantly decreased in the HgCl 2 -treated rats, which was rescued by the SC extract. Interestingly, both SC and HgCl 2 decreased GSH-PX activity in rat kidneys, whereas the SC þ Hg had similar GSH-PX activity as the Cont group. After oral administraion of the SC extract, the major constituents of SC were identified in the blood of rats ( Figure 1D ). Their relative proportions of the total chromatographic peak area are summarized in Supplementary Figure 1 and Table 1 , and Figs. 2 and 3) . Supplementary Figure 4 illustrates the total ion chromatogram of the SC extract investigated in the present study. The enrichment of major constituents of SC was evaluated by calculating their relative proportions of the total chromatographic peak area (Supplementary Table 6 ). It should be noted that the extraction of SC by ethanol was expected to obtain more enriched anthraquinones compared with aqueous extraction. Thus, the relative proportions of SC constituents listed in Supplementary Table 6 did not represent their real compositions in SC.
Interactions of SC Constituents With OAT1 and OAT3
To determine whether OATs were involved in SC-mediated protection against mercury toxicity, the interactions of 22 major SC constituents with the uptake of the fluorescent substrate 6-CF by OAT1-and OAT3-overexpressing HEK cells were investigated. As shown in our previous study, the uptake of 6-CF by OAT1 and OAT3 was linear for the first 10 min, and the K m values were determined to be 10.86 lM for OAT1 and 112.9 lM for OAT3 (Lu et al., 2017) . In this study, a substrate of 5 lM 6-CF and an incubation time of 5 min were used to quantify the initial rate of uptake. In the initial screening, the inhibition of the 22 compounds was evaluated at a concentration of 100 lM (Figure 2A ). An inhibitor is designated as a compound that results in >50% inhibition. As shown in Figure 2B , the majority of compounds showed inhibitory effects on OAT1 and OAT3, with 14 inhibiting OAT1 and 16 inhibiting OAT3. Among them, 14 compounds inhibited both OAT1 and OAT3, including 9 anthraquinones, 2 phenols, 1 naphthopyrone, and 2 fatty acids ( Figure 3C ). These inhibitors were validated by determining their IC 50 values in vitro (Figure 3 ) and are summarized in Supplementary Table 2 .
Inhibitory Mechanism of SC Constituents on OAT1 and OAT3 Lineweaver-Burk plots were used to determine the inhibitory mechanisms of selected compounds in each class (Figure 4) . Compound 11 is an unconjugated anthraquinone that inhibited both OAT1 (IC 50 ¼ 0.97 lM) and OAT3 (IC 50 ¼ 1.23 lM) at the lowest concentration. Compound 11 was a competitive inhibitor of OAT1, whereas it noncompetitively inhibited OAT3. In contrast, compound 6 is an anthraquinone glycoside that competitively inhibited both OAT1 (IC 50 ¼ 15.61 lM) and OAT3 (IC 50 ¼ 23.07 lM). The naphthopyrone compound 19 was a competitive inhibitor of OAT1 and OAT3, whereas phenol compound 14 and fatty acid compound 21 were noncompetitive inhibitors of both OAT1 and OAT3. Thus, the present findings confirmed that OAT1 and OAT3 are polyspecific transporters that can be inhibited by both competitive and noncompetitive mechanisms.
Effect of SC Constituents on Mercury-Induced Toxicity in Cell Cultures
Cell viability of HEK-OAT1 and HEK-OAT3 cells to the 22 isolated compounds at 10 and 50 lM after 18 h of exposure was evaluated to determine their in vitro toxicity. As shown in Figure 5 , all compounds at 10 lM had little effect on the viability of the transporter-expressing cells (>80% survival). However, when the cells were incubated with the 22 compounds at 50 lM for 18 h, significant toxicity was observed for compounds 1, 2, 3, 4, 21, and 22. The toxicity of mercury was evaluated in HEK-EV, HEK-OAT1, and HEK-OAT3 cells ( Figure 6A ). Both control and the two OAT-expressing cells showed similar sensitivity to HgCl 2 exposure for 18 h. Cellular viability in HEK-EV and the two HEK-OAT cell lines was reduced by 90% during the 18 h of exposure to 100 lM HgCl 2 . Compared with HgCl 2 , a high concentration of Cys-Hg was required to decrease viability in three cell lines. The inhibitory effects on 6-CF uptake by OAT1 and OAT3 with increasing concentrations of 6-CF were measured at various concentrations of compounds 11, 6, 14, 19, and 21, representing unconjugated anthraquinone, glycosided anthraquinone, phenol, naphthopyrone, and fatty acid, respectively. Each data point represents mean 6 SE, n ¼ 6.
After 18 h of Cys-Hg exposure, no significant toxicity was observed in the HEK-EV cells, whereas cellular viability was reduced about 65% in HEK-OAT1 and 50% in HEK-OAT3 cells, respectively. Thus, both OAT1 and OAT3 increased the toxicity of Cys-Hg in HEK cells.
If the toxic effect of the Cys-Hg is related to its cellular uptake, inhibition of OAT1 or OAT3 should reduce its toxicity. As shown in Figure 6B , when 200 lM Prob was coincubated with Cys-Hg, the survival of HEK-OAT1 cells increased from 35% to 65%. In contrast, Prob offered no protection to the toxicity of Cys-Hg in the HEK-OAT3 cells. When 10 lM SC constituents were coincubated with Cys-Hg, 11 compounds (7 anthraquinones, 1 phenol, and 3 naphthopyrones) were able to reduce the toxicity of Cys-Hg in HEK-OAT1 cells, whereas only 3 anthraquinone compounds reduced the toxicity of Cys-Hg toxicity in HEK-OAT3 cells ( Figure 6C ). It should be noted that this concentration was quite lower compared with those concentrations used in previous studies on the other in vitro biological effect of SC constituents (Jung et al., 2010 Yi et al., 2016) . In contrast, when 50 lM of the SC compounds were used, most of them reduced Cys-Hg toxicity in both HEK-OAT1 and HEK-OAT3 cells. The survival rates of HEK-OAT1 and HEK-OAT3 cells after incubating with Cys-Hg in the absence or presence of SC constituents are summarized in Supplementary Table 3 .
Comparative Modeling of OAT1 and OAT3
To facilitate the identification of OAT inhibitors from natural products, models of OAT1 and OAT3 were constructed on the basis of the structures of PiPT (PDB ID 4J05) and MdfA (PDB ID 4ZP2), respectively. The sequence identity is 33.6% between PiPT and OAT1, and 35.7% between MdfA and OAT3. The stereo chemical and accuracy of the predicted models were evaluated with PROCHECK and ERRAT programs ( Table 2) . The Ramachandran plot analysis showed that the majority of residues was sterically allowed (95.9% for OAT1; 97.3% for OAT3), suggesting that the quality of the model is good and reliable (Lovell et al., 2003) . ERRAT assesses the statistical organization of different types of atoms with respect to each other in the protein model, and thus evaluates the overall quality factor for nonbonded interactions. The ERRAT score is directly proportional to good model quality, with least accepted range of 50 (Colovos and Yeates, 1993) . In this study, ERRAT showed an overall quality factor of 86.41 for OAT1 and 88.02 for OAT3. Thus, both the Ramachandran and ERRAT results suggested that homology models of OAT1 ( Figure 7A ) and OAT3 ( Figure 7C ) are trustworthy for conducting further computational analysis.
To validate the accuracy of the comparative models, 10 known OAT1 and OAT3 inhibitors were chosen and docked Table 4 ). The favorable docking poses of these inhibitors are illustrated to predict the important residues of OAT1 ( Figure 7B ) and OAT3 ( Figure 7D ) that may form noncovalent interactions.
Predictive Values of OAT1 and OAT3 Comparative Models
To determine whether inhibitors of OAT1 and OAT3 could be predicted by docking simulation, each of the 22 SC compounds was docked against the predicted binding sites on the transporter models. The predicted binding free energies of these compounds are presented in Table 3 . The lower binding free energy indicates a higher inhibitory activity of the compound. The binding free energy between the OAT1-compound system and OAT3-compound system likely explains their relative recognition selectivity to OAT1 and OAT3. The best docking conformations of four typical structures, namely compounds 11 (anthraquinone), 14 (phenol), 19 (naphthopyrone), and 21 (fatty acid), were selected to investigate the binding modes of each class of compounds with OAT1 and OAT3 (Figure 8 ). In the OAT1-compound systems, compound 11 (aurantio-obtusin) formed a H-bond with Leu-426 and a p-p interaction with Tyr-242 ( Figure 8A and 8B) ; compound 14 (9-dehydroxyleurotinone) formed two H-bonds with His-337 and Leu-426 as well as a p-p interaction with Tyr-242 ( Figure 8E and 8F); compound 19 (nor-rubrofusarin-9-dehydrohyroxyeurotinone) formed H-bonds with Gln-335, Arg-466, Arg-131, Gly-196, and Gly-459 ( Figure 8I and 8J) ; and compound 21 (linolenic acid) formed H-bonds with Asn-97 and Arg-331 ( Figure 8M and  8N ). In the OAT3-compound systems, compound 11 formed two H-bonds with Met-446 and Met-230 ( Figure 8C and 8D) ; compound 14 formed a H-bond with Arg-325 ( Figure 8G and 8H) ; compound 19 formed H-bonds with Arg-325, Tyr-218, Asn-102, and Gly-98 ( Figure 8K and 8L); and compound 21 formed a H-bond with Arg-324 ( Figure 8O and 8P).
DISCUSSION
Semen cassiae is widely consumed as a tea and herbal medicine, and has been shown to protect against diabetic nephropathy (Kim et al.,2014) . This study extended its protective effect on kidney toxicity induced by mercury. Although SC extract could only partly reverse the serum biomarkers of kidney injury induced by HgCl 2 , it almost abolished the histological alterations caused by HgCl 2 . Further analysis revealed that cassiaside and auranto-obtusin were two major SC constituents in the blood of rats after SC treatment ( Figure 1D ). Additionally, several anthraquinones, such as obtusifolin, obtusin, physcion, and emodin, were also observed in rat blood after exposure to SC. Previous studies have suggested that OAT1 and OAT3 mediate the cellular uptake of mercury by the kidney (Aslamkhan et al., 2003; Zalups and Ahmad, 2005) . Physcion and emodin have been reported to inhibit OAT1 and OAT3 transport (Ma et al., 2014) . This prompted us to investigate the interactions of SC constituents with the uptake of 6-CF by OAT1 and OAT3. In this study, six of eight compounds in Figure 1D (cassiade, aurantio-obtusin, 2-O-methyl-9-dehydroxyeurotinone, obtusifolin, physcion, and emodin) showed strong inhibitory effects on the uptake of OAT1 and OAT3. Furthermore, these compounds also markedly protected against mercury toxicity in OAT1-overexpressing kidney cells. Therefore, the present study suggests that inhibition of OAT1 is the underlying mechanism for the protective effect of SC on mercury poisoning, and it is worth investigating the in vivo protective effect of these newly identified OAT1 inhibitors in the future study.
The exact role of OAT3 in transporting mercury from the peritubular blood into the intracellular compartment remains controversial. Aslamkhan et al. reported that rat Oat3 mediated the uptake of N-acetylcysteine-Hg 2þ and could be fully inhibited by 250 lM Prob (an OAT inhibitor) (Aslamkhan et al., 2003) . However, they did not further evaluate the link between Oat3 expression and the cytotoxicity of that mercuric-thiol conjugate. Torres et al. reported that mercury-induced renal injury observed in wild-type mice was almost abolished in Oat1-null mice, and thus concluded that mercury-induced kidney injury was mediated mainly by Oat1 (Torres et al., 2011) . However, the expression of Oat3 is also reduced in kidneys of Oat1-null mice, which could contribute to the protection of mercury poisoning. Furthermore, species differences have been demonstrated between humans and rodents in terms of their affinities to substrates and inhibitors. Thus, it remains obscure whether human OAT3 regulates the mercury-induced kidney toxicity. In the present study, the toxicity of HgCl 2 is similar among HEK-EV, HEK-OAT1, and HEK-OAT3 cells, suggesting OAT1 and OAT3 are not involved in transporting inorganic Hg 2, 4, 7, 8, 11, 15, 18 , and 20 at 10 lM. Except for compounds 18 and 20, all other compounds are potent inhibitors of OAT1. In contrast, the toxicity of Cys-Hg in HEK-OAT3 cells cannot be reversed by 200 lM Prob or most of the SC compounds at 10 lM. This suggests that inhibition of OAT3 cannot protect against Cys-Hg-induced toxicity in HEK-OAT3 cells. It is possible that overexpressing OAT3 causes alterations to other proteins in HEK cells, which may contribute to the susceptibility to Cys-Hg toxicity. Although many compounds at 50 lM showed protective effects on both HEK-OAT1 and HEK-OAT3 cells with Cys-Hg, the high concentrations of these compounds may exert other effects, such as antioxidant effect in cells. Therefore, the present study demonstrates that human OAT1, but not OAT3, plays a vital role in mercury-induced kidney toxicity.
Computational modeling and virtual screening of small molecule libraries have facilitated the identification and characterization of ligands of transporters. However, it remains challenging to accurately predict inhibitors of OAT1 and OAT3. A comparative model of OAT1 has been built using the structure of bacterial GlpT as the template. However, their sequence identity is very low, which unavoidably reduces its accuracy. In the present study, we built comparative models of OAT1 and OAT3 using two recently determined structures of eukaryotic PiPT and bacterial MdfA, respectively. The sequence identity is 33.6% between PiPT and OAT1, and 35.7% between MdfA and OAT3. Both the Ramachandran and ERRAT parameters suggest that the two comparative models are reliable (Table 1 ). The two homology models were further confirmed by 10 known structurally diverse inhibitors of OAT1 and OAT3, respectively. All of the inhibitors can be docked favorably against the predicted binding sites.
The current data suggest that inhibitors of OAT1 and OAT3 can be identified by a combination of homology model-based screening and in vitro screening. There are several studies aiming to identify inhibitors of OAT1 and OAT3 from clinical drugs. For instance, Duan et al. identified 92 inhibitors of OAT1 and 262 inhibitors of OAT3 by using a high throughput screening assay (Duan et al., 2012) . Compared with "western" drugs, the effect of natural products on OAT1 and OAT3 remains largely unknown. In the present study, 22 natural products isolated from SC were used to evaluate the predictive values of comparative models of OAT1 and OAT3. The predicted results were consistent with the in vitro data (Supplementary Table 4 ). For example, compound 3 has a predicted binding free energy of -16.21 kcal/mol for OAT1 and -18.05 kcal/mol for OAT3, respectively. Consistently, compound 3 at 100 lM has no inhibitory effect on these two OATs using OAT-expressing cells. Compound 4 has a predicted binding free energy of -42.5 and -39.3 kcal/mol for OAT1 and OAT3, respectively. The in vitro data show that compound 4 inhibited both OAT1 and OAT3 more than 80% when incubated at 100 lM. Furthermore, the predicted binding free energy could well explain the specificity of the inhibitors to OAT1 and OAT3. The binding free energy of compound 5 was -16.97 kcal/mol for OAT1 and -34.76 kcal/mol for OAT3. Consistently, compound 5 had little effect on OAT1-mediated 6-CF uptake, whereas it inhibited OAT3-mediated 6-CF uptake about 55%.
As pointed out by the International Transporter Consortium, understanding the inhibitory mechanisms remains to be improved in transporter studies in drug development (Tweedie et al., 2013) . The current data suggest that the inhibitory mechanisms of SC constituents are quite different between OAT1 and OAT3. Among the four structural classes of compounds isolated from SC, the order of their inhibition on OAT1 and OAT3 is anthraquinones > phenols > naphthopyrones > fatty acids. All four structures inhibit OATs to some extent, confirming that OAT1 and OAT3 are poly-specific transporters. A comparative model of OAT1 suggests that some residues, including Asn-97, Tyr-242, Arg-331, His-337, Leu-426, and Gly-459, play an important role in recognition of OAT1 inhibitors. In particular, Tyr-242 and Leu-426 in the OAT1 model form H-bonds or p-p interactions with both anthraquinones and phenols. As for OAT3, the important residues include Gly-98, Asn-102, Met-130, Tyr-218, Arg-324, Arg-325, and Met-446. There are five inhibitors for OAT1 and four inhibitors for OAT3 with IC 50 values <5 lM. All of these compounds are anthraquinones. Whereas the IC 50 values of compounds 4 and 11 are <5 lM for both OAT1 and OAT3, but their glycosides (compounds 5 and 12) have little inhibitory effects. Thus, unconjugated anthraquinones have a better affinity with OAT1 and OAT3 than their glycoside-conjugates. Additionally, the number of methoxy group also influences the inhibition potency of anthraquinones. When the hydroxyl group at R6 position of compound 2 is replaced by a methoxy group (compound 3), compound 2 losses its inhibitory effect on OAT1 and OAT3.
In conclusion, the present study demonstrates that SC extract has protective effects on mercury-induced AKI in rats, which appears to be attributed to the inhibitory effect of SC constituents on OAT1, but not OAT3. The present study indicates that inhibitors of OAT1 and OAT3 can be identified from natural products by combining in silico and in vitro screening methods.
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